Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090

Overview

• Gender

  ALL

• Age

  13 Months or less

• Phase

  PHASE3

• Study Type

  INTERVENTIONAL

• Location

  Hospital Prof. Dr. Fernando Fonseca (Amadora)
  Centro Hospitalar de Lisboa Ocidental | Clinical Research Department (Lisboa)
  

• Clinicaltrial.gov

  https://classic.clinicaltrials.gov/ct2/show/NCT04015180

Summary

This is a follow-up study to evaluate the long term outcome of babies treated in the FIREFLEYE study.

Conditions

Retinopathy of Prematurity (ROP)

Eligibility

Inclusion Criteria:

* Subject was treated in Study 20090
* Age less than 13 months of chronological age
* Signed informed consent from parent(s)/legally authorized representative(s), which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol

Exclusion Criteria:

- Subject has a condition preventing participation in the study, or performance of study procedures.

Details